Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during th...

por Woods, Patricia, Flynn, Maura, Monach, Paul, Visnaw, Karen, Schiller, Sara, Holmberg, Erika, Leatherman, Sarah, Ferguson, Ryan, Branch-Elliman, Westyn
Publicado 2021

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation

por Dassum, Samira Reyes, Ferguson, Ryan, Woods, Patricia, Flynn, Maura, Visnaw, Karen, Holmberg, Erika, Schiller, Sara, Shannon, Colleen, Brophy, Mary, Monach, Paul, Leatherman, Sarah, Branch-Elliman, Westyn
Publicado 2023

517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial

por Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew, Shah, Nishant, Taylor, Thomas H, Page, Sarah T, Schiller, Sara, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul
Publicado 2021

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial

por Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew D., Shah, Nishant R., Taylor, Thomas H., Page, Sarah T., Schiller, Sara J., Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul A.
Publicado 2022